H.C. Wainwright cuts Syndax Pharmaceuticals target price to $36 from $38
SNDX•H.C. Wainwright cut its target price for Syndax Pharmaceuticals to $36 from $38.
Related News
Waystar Holding Corp.: Raymond James raises target price to $35 from $32
WAY•
Roku, Inc.: Rosenblatt Securities cuts to neutral from buy
ROKU•
Phinia to participate in Stephens Annual Investment Conference
PHIN•
XPLR Infrastructure announces availability of third-quarter 2026 financial results release
XIFR•
NextEra, Dominion accept most Virginia merger conditions
NEE•